Ikarian Capital, LLC Q2 2022 Filing

Filed August 12, 2022

Portfolio Value

$548.4M

Holdings

115

Report Date

Q2 2022

Filing Type

13F-HR

All Holdings (115 positions)

#StockSharesValue% PortfolioType
101
MYMDMYMD PHARMACEUTICALS INC
81,089$176K0.03%
102
MBIOUSDMUSTANG BIO INC
246,824$145K0.03%
103
OVASUSDTEMPEST THERAPEUTICS INC
61,827$132K0.02%
104
STEALTH BIOTHERAPEUTICS CORP
501,836$127K0.02%
105
CYCLACEL PHARMACEUTICALS INC
104,741$113K0.02%
106
LRMRLARIMAR THERAPEUTICS INC
51,606$100K0.02%
107
IVAINVENTIVA SA
15,579$93K0.02%
108
DRUGBRIGHT MINDS BIOSCIENCES INC
105,958$86K0.02%
109
MIND MEDICINE MINDMED INC
105,958$68K0.01%
110
OVIDOVID THERAPEUTICS INC
26,831$59K0.01%
111
ENVERIC BIOSCIENCES INC
223,834$48K0.01%
112
ALTAMIRA THERAPEUTICS LTD
75,000$36K0.01%
113
BAUDAX BIO INC
2,966$3K0.00%
114
290ACHINOOK THERAPEUTICS INC
332,295$00.00%
115
OTICEUROTONOMY INC
180$00.00%
PreviousPage 2 of 2